David S. Resnick

David Resnick is the team leader of the Patent group and he works with startup and established companies, as well as major U.S. research institutions, to develop comprehensive patent strategies to protect their intellectual property.

What do you focus on?

My practice is focused on strategic portfolio management, patent prosecution, transactional matters and associated client counseling. I manage the patent portfolios of some of the leading U.S. research institutions and domestic and international corporations. I also represent some of the world’s most recognized life sciences corporations before the U.S. Patent and Trademark Office. I have extensive experience in the life sciences and have particular experience in the areas of pharmacogenomics, proteomics and disease biomarkers and their application in the evolving field of personalized medicine.

I’ve written articles on patent prosecution practice, personalized medicine and technology issues for Nature Biotechnology, The Journal of Biolaw & Business, Personalized Medicine and other publications. I’m also a member of the editorial board of Pharmaceutical Patent Analyst.

Strategic portfolio management

I regularly assist clients in building and evaluating their intellectual property portfolios as well as in evaluating the intellectual property held by competitors. I regularly conduct freedom-to-operate analyses and prepare infringement and validity opinions involving complex and cutting-edge technologies.

Patent prosecution

I assist clients with patent prosecution in the areas of:

• Molecular biology, genetics, biochemistry and immunology
• Pharmaceuticals, including oncology
• Diagnostics
• Stem cells/regenerative medicine
• Medical devices
• Microfluidic devices

Transactions and related counseling

I work closely with my clients to identify and analyze acquisition targets and regularly conduct due diligence related to potential acquisitions.